Literature DB >> 19106389

Secular trends in the incidence of and risk factors for ischemic stroke and its subtypes in Japanese population.

Michiaki Kubo1, Jun Hata, Yasufumi Doi, Yumihiro Tanizaki, Mitsuo Iida, Yutaka Kiyohara.   

Abstract

BACKGROUND: The study of long-term trends in the incidence of and risk factors for ischemic stroke subtypes could offer insights into primary and secondary prevention. METHODS AND
RESULTS: We established 3 cohorts of residents >/=40 years of age in 1961, 1974, and 1988 in the Japanese community of Hisayama. Morphological examinations by autopsy or brain imaging were performed on most of the ischemic stroke cases developed in these cohorts. When 13-year follow-up data were compared, the age-adjusted incidence of ischemic stroke and lacunar infarction declined significantly from the first to the third cohort for both sexes, whereas the incidences of atherothrombotic and cardioembolic infarction did not change during this period. Hypertension was a powerful risk factor for the development of ischemic stroke, and improvement of hypertension control would have largely influenced this declining trend: The age- and sex-adjusted hazard ratio of hypertension decreased from 3.25 (95% CI 2.17 to 4.86) in the first cohort to 1.83 (1.29 to 2.58) in the third cohort. A rapid increase in the prevalence of metabolic disorders may have offset the impact of improvements in hypertension control and resulted in a slowdown of the decline in the incidence of ischemic stroke in the cohorts in the present study; however, hypertension still makes a large contribution to the development of ischemic stroke.
CONCLUSIONS: These findings suggest that in the Japanese population, the incidence of ischemic stroke has declined significantly over the past 40 years, probably owing to better management of hypertension. There is a need for greater primary prevention efforts in the treatment of hypertension and metabolic disorders.

Entities:  

Mesh:

Year:  2008        PMID: 19106389     DOI: 10.1161/CIRCULATIONAHA.107.743211

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  29 in total

1.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

2.  Long-term effects of AST-120 on the progression and prognosis of pre-dialysis chronic kidney disease: a 5-year retrospective study.

Authors:  Eiichi Sato; Atsushi Tanaka; Jun-Ichi Oyama; Ayumu Yamasaki; Mitsuhiro Shimomura; Atsushi Hiwatashi; Yoshihiko Ueda; Mayuko Amaha; Mayumi Nomura; Daisuke Matsumura; Tsukasa Nakamura; Koichi Node
Journal:  Heart Vessels       Date:  2015-12-23       Impact factor: 2.037

3.  Persistent ischemic stroke disparities despite declining incidence in Mexican Americans.

Authors:  Lewis B Morgenstern; Melinda A Smith; Brisa N Sánchez; Devin L Brown; Darin B Zahuranec; Nelda Garcia; Kevin A Kerber; Lesli E Skolarus; William J Meurer; James F Burke; Eric E Adelman; Jonggyu Baek; Lynda D Lisabeth
Journal:  Ann Neurol       Date:  2013-08-13       Impact factor: 10.422

4.  Trends in stroke incidence rates and stroke risk factors in Rotterdam, the Netherlands from 1990 to 2008.

Authors:  Renske G Wieberdink; M Arfan Ikram; Albert Hofman; Peter J Koudstaal; Monique M B Breteler
Journal:  Eur J Epidemiol       Date:  2012-03-17       Impact factor: 8.082

5.  Combined impact of lifestyle-related factors on total and cause-specific mortality among Chinese women: prospective cohort study.

Authors:  Sarah J Nechuta; Xiao-Ou Shu; Hong-Lan Li; Gong Yang; Yong-Bing Xiang; Hui Cai; Wong-Ho Chow; Butian Ji; Xianglan Zhang; Wanqing Wen; Yu-Tang Gao; Wei Zheng
Journal:  PLoS Med       Date:  2010-09-14       Impact factor: 11.069

Review 6.  Systolic hypertension: an increasing clinical challenge in Asia.

Authors:  Jeong Bae Park; Kazuomi Kario; Ji-Guang Wang
Journal:  Hypertens Res       Date:  2014-12-11       Impact factor: 3.872

Review 7.  Genetics of cerebral small vessel disease.

Authors:  Jay Chol Choi
Journal:  J Stroke       Date:  2015-01-30       Impact factor: 6.967

8.  Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis.

Authors:  Shu-Yang Li; Yoichi Yoshida; Eiichi Kobayashi; Masaaki Kubota; Tomoo Matsutani; Seiichiro Mine; Toshio Machida; Yoshiro Maezawa; Minoru Takemoto; Koutaro Yokote; Yoshio Kobayashi; Hirotaka Takizawa; Mizuki Sata; Kazumasa Yamagishi; Hiroyasu Iso; Norie Sawada; Shoichiro Tsugane; Sohei Kobayashi; Kazuyuki Matsushita; Fumio Nomura; Hisahiro Matsubara; Makoto Sumazaki; Masaaki Ito; Satoshi Yajima; Hideaki Shimada; Katsuro Iwase; Hiromi Ashino; Hao Wang; Kenichiro Goto; Go Tomiyoshi; Natsuko Shinmen; Rika Nakamura; Hideyuki Kuroda; Yasuo Iwadate; Takaki Hiwasa
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

9.  Adiposity and risk of cardiovascular diseases in Japan: secular trend, individual level associations and causal pathway - implications for the prevention of cardiovascular diseases in societies with rapid economic development.

Authors:  Hiroshi Yatsuya; Kazumasa Yamagishi; Hiroyasu Iso
Journal:  EPMA J       Date:  2011-03-27       Impact factor: 6.543

10.  Serum adiponectin level is not only decreased in metabolic syndrome but also in borderline metabolic abnormalities.

Authors:  M Y Baden; Y Yamada; Y Obata; Y Hosakawa; K Saisho; S Tamba; K Yamamoto; M Umeda; A Furubayashi; Y Tsukamoto; Y Matsuzawa
Journal:  Nutr Diabetes       Date:  2011-10-10       Impact factor: 5.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.